Cognition Therapeutics Inc — Cash Flow (NASDAQ:CGTX) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Cash from operating activities -3.63 M-18.53 M-16.02 M-28.47 M -29.53 M Cash from investing activities -27 K-171 K-147 K-4 000 — Cash from financing activities 53.2 M5.55 M4.52 M23.57 M 47.35 M Free cash flow -3.66 M-18.7 M-16.16 M-28.48 M -29.53 M

뉴스

Cognition Therapeutics, FDA와 루이체 치매 약물 관련 회의

Cognition Therapeutics holds FDA meeting on Lewy bodies dementia drug

코그니션, DLB 치료제 2상 시험서 긍정적 결과 보여

Cognition’s DLB drug shows positive results in phase 2 trial

코그니션 테라퓨틱스, 확대 접근 프로그램 등록 완료

Cognition Therapeutics completes enrollment in expanded access program

코그니션 테라퓨틱스, 알츠하이머 치료제 3상 계획 발표

Cognition Therapeutics outlines Phase 3 plans for Alzheimer’s drug

Cognition Therapeutics: A High-Stakes Bet On A Single Drug - Why I Hold (NASDAQ:CGTX)

Cognition Therapeutics, 알츠하이머 약물 임상 완료

Cognition Therapeutics completes enrollment in Alzheimer’s drug trial

Has ANI Pharmaceuticals (ANIP) Outpaced Other Medical Stocks This Year?